Related Experiment Video
Updated: Jun 22, 2026

13:33
Infinium Assay for Large-scale SNP Genotyping Applications
Published on: November 19, 2013
39.1K
Focus on your locus with a massively parallel reporter assay
Jessica C McAfee1,2, Jessica L Bell1,2, Oleh Krupa1,2
1Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Journal of Neurodevelopmental Disorders
|September 9, 2022
Summary
Massively parallel reporter assays (MPRAs) functionally validate thousands of genetic variants linked to neurodevelopmental disorders. This high-throughput method helps identify causal variants and understand their molecular effects.
Area of Science:
- Genomics
- Neuroscience
- Molecular Biology
Background:
- Genome-wide association and whole genome sequencing studies identify numerous genetic variants associated with neurodevelopmental disorders.
- Causal variants within large noncoding haplotype blocks and the functional impact of rare noncoding variants remain challenging to determine without experimental validation.
Purpose of the Study:
- To review and discuss the application of Massively Parallel Reporter Assays (MPRAs) for the functional validation of genetic variants implicated in neurodevelopmental disorders.
- To explore various MPRA designs and their potential for future research in this field.
Main Methods:
- Massively Parallel Reporter Assays (MPRAs) enable simultaneous functional validation of thousands of regulatory elements.
- MPRAs utilize high-throughput sequencing and barcode technology to assess gene regulatory effects of genetic variants.
- Adaptations of MPRA measure cis- and trans-regulatory effects and posttranscriptional processes.
Main Results:
- MPRAs can screen thousands of sequences in a single experiment, significantly narrowing down potential causal genetic variants.
- This technique provides functional insights into the molecular effects of genetic variants associated with neurodevelopmental disorders.
Conclusions:
- MPRAs are a powerful tool for experimentally validating genetic variants linked to neurodevelopmental disorders, despite limitations like the lack of genomic context modeling.
- Future applications of MPRA include studying gene-by-environment interactions and pharmacogenetics in the context of neurodevelopmental disorders.

